Stockscreener 앱 받기
28.77
0.86%
-0.25
전일 마감가:
$29.02
열려 있는:
$29.16
하루 거래량:
311.55K
Relative Volume:
0.67
시가총액:
$1.54B
수익:
-
순이익/손실:
$-83.74M
주가수익비율:
-17.87
EPS:
-1.61
순현금흐름:
$-64.98M
1주 성능:
-1.84%
1개월 성능:
+25.25%
6개월 성능:
+163.46%
1년 성능:
+78.14%
1일 변동 폭
$28.15
$29.46
1주일 범위
$27.50
$29.78
52주 변동 폭
$6.42
$30.70
Tyra Biosciences Inc Stock (TYRA) Company Profile
명칭
Tyra Biosciences Inc
전화
(619) 728-4760
주소
2656 STATE STREET, CARLSBAD
TYRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
28.77 | 1.55B | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-05-21 | 재개 | Piper Sandler | Overweight |
| 2025-01-07 | 개시 | UBS | Buy |
| 2024-10-18 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-08-15 | 개시 | Piper Sandler | Overweight |
| 2023-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-06-30 | 개시 | Wedbush | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-06-23 | 개시 | H.C. Wainwright | Buy |
| 2022-03-08 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-11-08 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-10-11 | 개시 | Cowen | Outperform |
| 2021-10-11 | 개시 | Jefferies | Buy |
모두보기
Tyra Biosciences Inc 주식(TYRA)의 최신 뉴스
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Non-Muscle Invasive Bladder Cancer Pipeline and Clinical Trial - openPR.com
Tyra Biosciences (TYRA) Is Up 9.4% After New COO Hire And 52-Week High Has The Bull Case Changed? - Sahm
Can Tyra Biosciences Inc. stock surprise with earnings upsideJuly 2025 Drop Watch & Technical Entry and Exit Alerts - Улправда
About Us | Cabling Installation & MaintenanceTyra Biosciences, Inc.Common Stock (Nasdaq:TYRA) Price Chart - FinancialContent
Tyra Biosciences, Inc. (TYRA) Stock Analysis: A Biotech With A Potential 10.61% Upside - DirectorsTalk Interviews
Is Tyra Biosciences Inc. stock a dividend growth opportunity2025 Key Lessons & Weekly High Return Forecasts - Улправда
Tyra Biosciences stock hits 52-week high at $30.27 By Investing.com - Investing.com India
Tyra Biosciences stock hits 52-week high at $30.27 - Investing.com
How Tyra Biosciences Inc. stock reacts to global recession fearsPortfolio Risk Summary & AI Driven Stock Reports - Улправда
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month HighHere's Why - MarketBeat
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $32 - 富途牛牛
Promising Growth Stocks To Follow Now – January 5th - Defense World
Tyra Biosciences (NASDAQ:TYRA) Shares Down 6%What's Next? - MarketBeat
Is Tyra Biosciences Inc a good long term investmentInsider Selling Patterns & Fast Growing Investment Ideas - earlytimes.in
Tyra Biosciences (NASDAQ:TYRA) Rating Increased to Hold at Wall Street Zen - MarketBeat
(TYRA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
June Brings on Some Huge Insider Buying - AOL.com
Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a 25% Upside Potential in the Biotech Space - DirectorsTalk Interviews
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year High – Still a Buy? - Defense World
Tyra Biosciences stock hits 52-week high at $26.36 By Investing.com - Investing.com Nigeria
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Tyra Biosciences stock hits 52-week high at $26.36 - Investing.com
Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $37 - 富途牛牛
Is Tyra Biosciences Inc. stock gaining market shareMACD Histogram Signals & Start Learning With Our Courses - bollywoodhelpline.com
Tyra Biosciences (NASDAQ:TYRA) Cut to Sell at Wall Street Zen - MarketBeat
Tyra Biosciences Reports Increased Loss Amid R&D Investments - MSN
Tyra Biosciences (NASDAQ:TYRA) Reaches New 52-Week HighHere's What Happened - MarketBeat
Does Tyra Biosciences (TYRA) Index Inclusion Mark a Turning Point in Its Institutional Story? - Yahoo Finance
Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally - Yahoo Finance
(TYRA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Tyra Biosciences director more sells $250k in shares By Investing.com - Investing.com South Africa
Tyra Biosciences director more sells $250k in shares - Investing.com
Tyra Biosciences, Inc.(NasdaqGS: TYRA) added to S&P Biotechnology Select Industry Index - marketscreener.com
Will Tyra Biosciences Inc. stock remain a Wall Street favorite2025 Winners & Losers & AI Powered Trade Plan Recommendations - Улправда
Tyra Biosciences (TYRA) Is Up 12.7% After Wedbush Highlights Pipeline Momentum And Leadership RefreshWhat's Changed - Sahm
Tyra Biosciences (NASDAQ:TYRA) Director Sells $250,000.00 in Stock - MarketBeat
Chmn More Sells 10,000 ($250K) Of Tyra Biosciences Inc [TYRA] - TradingView — Track All Markets
Tyra Biosciences stock hits 52-week high at 24.05 USD By Investing.com - Investing.com Nigeria
Tyra Biosciences (NASDAQ:TYRA) Sets New 52-Week HighHere's What Happened - MarketBeat
Tyra Biosciences stock hits 52-week high at 24.05 USD - Investing.com
Why Tyra Biosciences Inc. stock attracts high net worth investorsForecast Cut & Daily Profit Focused Stock Screening - Улправда
Growth Recap: Will Tyra Biosciences Inc. stock remain a Wall Street favoriteMarket Activity Summary & Low Risk Entry Point Guides - Улправда
Tyra Biosciences Inc (TYRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tyra Biosciences Inc 주식 (TYRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MORE ROBERT J | Director |
Dec 19 '25 |
Sale |
25.00 |
10,000 |
250,000 |
3,823,425 |
| Bensen Daniel | Chief Discovery Officer |
Dec 12 '25 |
Sale |
22.64 |
8,000 |
181,159 |
162,981 |
4.73%
0.92%
자본화:
|
볼륨(24시간):